Spero Therapeutics, Inc. Share Price Börse Stuttgart
Stocks
2HA
US84833T1034
Biotechnology & Medical Research
|
Market Closed -
Börse Stuttgart
01:25:14 10/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.056 EUR | +5.28% |
|
-9.96% | -47.38% |
| 13/08 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 13/08 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 6.99Cr 6.24Cr 5.81Cr 5.28Cr 9.97Cr 676.32Cr 10Cr 70Cr 27Cr 344.81Cr 26Cr 26Cr 1.11TCr | P/E 2026 * |
-2.07x | P/E 2027 * | -11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 6.99Cr 6.24Cr 5.81Cr 5.28Cr 9.97Cr 676.32Cr 10Cr 70Cr 27Cr 344.81Cr 26Cr 26Cr 1.11TCr | EV / Sales 2026 * |
271x | EV / Sales 2027 * | - |
| Free-Float |
77.34% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SPRO | Delayed | |
CBOE
| SPRO | Real-time | |
|
Tradegate
| 2HA | Real-time | |
|
Boerse Muenchen
| 2HA | Real-time | |
|
Deutsche Boerse AG
| 2HA | Delayed | |
|
Börse Stuttgart
| 2HA | Delayed |
Last Transcript: Spero Therapeutics, Inc.
| 1 week | +0.67% | ||
| Current month | -0.47% | ||
| 1 month | +5.49% | ||
| 3 months | -42.98% | ||
| 6 months | -55.10% | ||
| Current year | -44.60% |
| 1 week | 1 |  | 1.08 |
| 1 month | 0.95 | | 1.22 |
| 3 years | 0.49 | | 2.6 |
| 5 years | 0.49 | | 15.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Esther Rajavelu
CEO | Chief Executive Officer | 47 | 10/01/2025 |
Debra Zack
CTO | Chief Tech/Sci/R&D Officer | 69 | 27/07/2026 |
Timothy Keutzer
COO | Chief Operating Officer | 58 | 01/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Milind Deshpande
CHM | Chairman | 69 | 01/01/2014 |
| Director/Board Member | 62 | 01/09/2015 | |
Frank Thomas
CHM | Chairman | 56 | 10/01/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.28% | -9.96% | -44.94% | -0.19% | 6.64Cr | |
| -2.59% | -5.70% | +40.86% | +83.11% | 7.21TCr | |
| +3.23% | -10.67% | +4.87% | +55.97% | 4.94TCr | |
| +1.56% | +1.17% | +5.15% | +33.38% | 4.72TCr | |
| +0.87% | -8.17% | +298.53% | +645.03% | 4.03TCr | |
| +0.39% | +0.65% | +28.02% | +30.24% | 4.26TCr | |
| +1.24% | -1.01% | +5.56% | +105.14% | 3.98TCr | |
| -2.13% | -2.18% | +7.51% | +50.31% | 3.05TCr | |
| +5.32% | +0.06% | -7.20% | -11.30% | 2.31TCr | |
| +3.78% | +8.33% | +18.40% | +0.33% | 2.11TCr | |
| Average | +1.30% | -3.91% | +35.68% | +99.20% | 4.07TCr | |
| Weighted average by Cap. | +0.78% | -4.28% | +47.31% | +117.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3L 2L 2L 2L 4L 2.5Cr 4L 25.8L 10.11L 1.27Cr 10L 9L 4.09Cr | - |
| Net income | -3.35Cr -2.99Cr -2.78Cr -2.53Cr -4.77Cr -323.78Cr -4.79Cr -33Cr -13Cr -165.07Cr -13Cr -12Cr -529.73Cr | -5.15Cr -4.6Cr -4.28Cr -3.89Cr -7.35Cr -498.42Cr -7.38Cr -51Cr -20Cr -254.11Cr -19Cr -19Cr -815.46Cr |
| Net Debt | - | - |
| Date | Price | Change |
|---|---|---|
| 09/26/09 | €1.056 | +5.28% |
| 08/26/08 | €1.003 | -2.53% |
| 07/26/07 | €1.029 | -1.15% |
| 06/26/06 | €1.041 | +1.36% |
| 05/26/05 | €1.027 | -2.10% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SPRO Stock
- 2HA Stock
Select your edition
All financial news and data tailored to specific country editions
